175 related articles for article (PubMed ID: 22645448)
1. Magnetic resonance spectroscopy of the breast at 3T: pre- and post-contrast evaluation for breast lesion characterization.
Kousi E; Tsougos I; Vasiou K; Theodorou K; Poultsidi A; Fezoulidis I; Kappas C
ScientificWorldJournal; 2012; 2012():754380. PubMed ID: 22645448
[TBL] [Abstract][Full Text] [Related]
2. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
[TBL] [Abstract][Full Text] [Related]
3. Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women.
Faeghi F; Baniasadipour B; Jalalshokouhi J
Asian Pac J Cancer Prev; 2015; 16(18):8335-8. PubMed ID: 26745081
[TBL] [Abstract][Full Text] [Related]
4. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of single voxel 1H MR spectroscopic imaging at 3T for the differentiation of benign and malign breast lesions.
Ramazan A; Demircioglu O; Ugurlu U; Kaya H; Aribal E
Clin Imaging; 2016; 40(5):831-6. PubMed ID: 27179154
[TBL] [Abstract][Full Text] [Related]
6.
Montemezzi S; Cavedon C; Camera L; Meliadò G; Caumo F; Baglio I; Sardanelli F
Radiol Med; 2017 Mar; 122(3):161-170. PubMed ID: 27981485
[TBL] [Abstract][Full Text] [Related]
7. Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings.
Sharma U; Agarwal K; Hari S; Mathur SR; Seenu V; Parshad R; Jagannathan NR
Magn Reson Imaging; 2019 Sep; 61():66-72. PubMed ID: 31128225
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.
Aribal E; Asadov R; Ramazan A; Ugurlu MÜ; Kaya H
Eur J Radiol; 2016 May; 85(5):979-86. PubMed ID: 27130059
[TBL] [Abstract][Full Text] [Related]
9. The contribution of diffusion tensor imaging and magnetic resonance spectroscopy for the differentiation of breast lesions at 3T.
Tsougos I; Svolos P; Kousi E; Athanassiou E; Theodorou K; Arvanitis D; Fezoulidis I; Vassiou K
Acta Radiol; 2014 Feb; 55(1):14-23. PubMed ID: 23864060
[TBL] [Abstract][Full Text] [Related]
10. (1)H MR spectroscopy with external reference solution at 1.5 T for differentiating malignant and benign breast lesions: comparison using qualitative and quantitative approaches.
Mizukoshi W; Kozawa E; Inoue K; Saito N; Nishi N; Saeki T; Kimura F
Eur Radiol; 2013 Jan; 23(1):75-83. PubMed ID: 22777619
[TBL] [Abstract][Full Text] [Related]
11. Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T.
Meisamy S; Bolan PJ; Baker EH; Pollema MG; Le CT; Kelcz F; Lechner MC; Luikens BA; Carlson RA; Brandt KR; Amrami KK; Nelson MT; Everson LI; Emory TH; Tuttle TM; Yee D; Garwood M
Radiology; 2005 Aug; 236(2):465-75. PubMed ID: 16040903
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of spectral selected press sequence in breast lesion characterization.
Lu H; Liu PF; Bao RX; Sun F
Chin Med Sci J; 2006 Dec; 21(4):265-9. PubMed ID: 17249203
[TBL] [Abstract][Full Text] [Related]
13. Interaction of gadolinium-based MR contrast agents with choline: implications for MR spectroscopy (MRS) of the breast.
Lenkinski RE; Wang X; Elian M; Goldberg SN
Magn Reson Med; 2009 Jun; 61(6):1286-92. PubMed ID: 19365855
[TBL] [Abstract][Full Text] [Related]
14. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study.
Jacobs MA; Barker PB; Argani P; Ouwerkerk R; Bhujwalla ZM; Bluemke DA
J Magn Reson Imaging; 2005 Jan; 21(1):23-8. PubMed ID: 15611934
[TBL] [Abstract][Full Text] [Related]
15. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy?
Tozaki M; Fukuma E
AJR Am J Roentgenol; 2009 Sep; 193(3):840-9. PubMed ID: 19696300
[TBL] [Abstract][Full Text] [Related]
16. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
[TBL] [Abstract][Full Text] [Related]
17. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
Cecil KM; Schnall MD; Siegelman ES; Lenkinski RE
Breast Cancer Res Treat; 2001 Jul; 68(1):45-54. PubMed ID: 11678308
[TBL] [Abstract][Full Text] [Related]
18. Single voxel in vivo proton magnetic resonance spectroscopy of breast lesions: experience in 77 cases.
Başara I; Örgüç Ş; Coşkun T
Diagn Interv Radiol; 2013; 19(3):221-6. PubMed ID: 23271501
[TBL] [Abstract][Full Text] [Related]
19. [Comprehensive magnetic resonance imaging for breast cancer].
Meladze NV; Ternovoĭ SK; Sharia MA; Solopova AE
Ter Arkh; 2013; 85(4):29-33. PubMed ID: 23808288
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of breast proton magnetic resonance spectroscopy at 1.5T in different histopathological types.
Baek HM
ScientificWorldJournal; 2012; 2012():508295. PubMed ID: 22654620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
